Table.
Characteristics for abdominal aortic aneurysm (AAA) and control patients
| Control (n = 92) | AAA (n = 78) | P value | |
|---|---|---|---|
|
| |||
| Age, years | 75.2 ± 0.6 | 73.5 ± 0.7 | .0683 |
| Male | 69 (75) | 57 (73) | .8609 |
| Hypertension | 70 (76) | 58 (74) | .8591 |
| Diabetes | 18 (20) | 12 (15) | .5475 |
| Smoking history | 82 (89) | 71 (91) | .7997 |
| COPD | 9 (10) | 22 (28) | .0026 |
| β-blocker | 48 (52) | 37 (47) | .6444 |
| ACE inhibitor | 35 (38) | 23 (29) | .2597 |
| Aspirin | 69 (75) | 54 (69) | .4916 |
| Ca++ channel blocker | 22 (24) | 11 (14) | .1224 |
| AAA size, cm | 2.18 ± 0.07 | 5.06 ± 0.13 | <.0001 |
| Family AAA | 9 (10) | 11 (14) | .4755 |
| Anti-inflammatory drug | 7 (8) | 11 (14) | .2136 |
ACE, Angiotensin-converting enzyme; COPD, chronic obstructive pulmonary disease.
Continuous data are presented as mean ± standard deviation and categorical data as number (%). Boldface values indicate statistical significance.